238 related articles for article (PubMed ID: 24930641)
1. Efficacy and safety of proton pump inhibitors (PPIs) plus rebamipide for endoscopic submucosal dissection-induced ulcers: a meta-analysis.
Wang J; Guo X; Ye C; Yu S; Zhang J; Song J; Cao Z; Wang J; Liu M; Dong W
Intern Med; 2014; 53(12):1243-8. PubMed ID: 24930641
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis.
Liu J; Xiong Z; Geng X; Cui M
Biomed Res Int; 2020; 2020():7196782. PubMed ID: 33062694
[TBL] [Abstract][Full Text] [Related]
3. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
[TBL] [Abstract][Full Text] [Related]
4. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
[TBL] [Abstract][Full Text] [Related]
5. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
[TBL] [Abstract][Full Text] [Related]
7. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
Fujiwara S; Morita Y; Toyonaga T; Kawakami F; Itoh T; Yoshida M; Kutsumi H; Azuma T
J Gastroenterol; 2011 May; 46(5):595-602. PubMed ID: 21359522
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study.
Kato T; Araki H; Onogi F; Ibuka T; Sugiyama A; Tomita E; Nagaki M; Moriwaki H
J Gastroenterol; 2010 Mar; 45(3):285-90. PubMed ID: 19957195
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
Jung DH; Park JC; Lee YC; Lee SK; Shin SK; Chung H; Park JJ; Kim JH; Youn YH; Park H
J Clin Gastroenterol; 2021 Mar; 55(3):233-238. PubMed ID: 32341237
[TBL] [Abstract][Full Text] [Related]
11. The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial.
Lee JY; Jang JS
Arab J Gastroenterol; 2021 Jun; 22(2):115-120. PubMed ID: 33551349
[TBL] [Abstract][Full Text] [Related]
12. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
Takayama M; Matsui S; Kawasaki M; Asakuma Y; Sakurai T; Kashida H; Kudo M
World J Gastroenterol; 2013 Sep; 19(34):5706-12. PubMed ID: 24039365
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers.
Yan B; Lu Z; Ge Z; Liu S; Guo X; Tian D; Yang Y; Li X; Gong W; Liu Z; Liu M; Zhou B; Zhao K; Pan F; Yang J; Yang Y
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00008. PubMed ID: 30702488
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide solution: a novel submucosal injection material to promote healing speed and healing quality of ulcers induced by endoscopic submucosal dissection.
Fujimoto A; Uraoka T; Nishizawa T; Shimoda M; Goto O; Ochiai Y; Maehata T; Akimoto T; Mitsunaga Y; Sasaki M; Yamamoto H; Yahagi N
Gastrointest Endosc; 2018 Apr; 87(4):1114-1120. PubMed ID: 28993136
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
[TBL] [Abstract][Full Text] [Related]
17. Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.
Pittayanon R; Martel M; Barkun A
J Gastroenterol Hepatol; 2018 Dec; 33(12):1948-1955. PubMed ID: 29870582
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study.
Higuchi K; Takeuchi T; Uedo N; Takeuchi Y; Naito Y; Yagi N; Tominaga K; Machida H; Tamada T; Morita Y; Yazumi S; Yamao J; Iguchi M; Azuma T
Gastric Cancer; 2015 Jul; 18(3):612-7. PubMed ID: 25098924
[TBL] [Abstract][Full Text] [Related]
19. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.
Park JH; Baek EK; Choi CH; Lee KH; Kim BJ; Kim JW; Kim JG; Chang SK
Surg Endosc; 2014 Jan; 28(1):235-41. PubMed ID: 23996340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]